ArticleAmerican journal of public health2012
Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger.
Article in American journal of public health, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 47 citations in OpenAlex.
- Strategic Planning of a Joint SARS-CoV-2 and Influenza Vaccination Campaign in the UK.Vaccines · 2024Article
- When increasing vegetable production may worsen food availability gaps: A simulation model in India.Food policy · 2023Article
- Article
- A systems map of the economic considerations for vaccination: Application to hard-to-reach populations.Vaccine · 2021Article
- Should countries switch to using five- or ten-dose rotavirus vaccines now that they are available?Vaccine · 2021Article
- Using Simulation Modeling to Guide the Design of the Girl Scouts Fierce & Fit Program.Obesity (Silver Spring, Md.) · 2020Article
- How coping can hide larger systems problems: the routine immunisation supply chain in Bihar, India.BMJ global health · 2019Article
- Article
- Economic impact of thermostable vaccines.Vaccine · 2017Article
- Article
- A systems approach to vaccine decision making.Vaccine · 2017Article
- Article
- The impact of implementing a demand forecasting system into a low-income country's supply chain.Vaccine · 2016Article
- Modular vaccine packaging increases packing efficiency.Vaccine · 2015Article
- Economics and financing of vaccines for diarrheal diseases.Human vaccines & immunotherapeutics · 2014Review
- Article
- Augmenting transport versus increasing cold storage to improve vaccine supply chains.PloS one · 2013Article
- Prevention of influenza in healthy children.Expert review of anti-infective therapy · 2012Review
- Bridging the gap from knowledge to delivery in the control of childhood diarrhoea.Bulletin of the World Health Organization · 2012Article
- It's a long, long walk: accessibility to hospitals, maternity and integrated health centers in Niger.International journal of health geographics · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 1 institution in 1 country.
Funding
Abstract
objectivesWe investigated whether introducing the rotavirus and pneumococcal vaccines, which are greatly needed in West Africa, would overwhelm existing supply chains (i.e., the series of steps required to get a vaccine from the manufacturers to the target population) in Niger.
methodsAs part of the Bill and Melinda Gates Foundation-funded Vaccine Modeling Initiative, we developed a computational model to determine the impact of introducing these new vaccines to Niger's Expanded Program on Immunization vaccine supply chain.
resultsIntroducing either the rotavirus vaccine or the 7-valent pneumococcal conjugate vaccine could overwhelm available storage and transport refrigerator space, creating bottlenecks that would prevent the flow of vaccines down to the clinics. As a result, the availability of all World Health Organization Expanded Program on Immunization vaccines to patients might decrease from an average of 69% to 28.2% (range = 10%-51%). Addition of refrigerator and transport capacity could alleviate this bottleneck.
conclusionsOur results suggest that the effects on the vaccine supply chain should be considered when introducing a new vaccine and that computational models can help assess evolving needs and prevent problems with vaccine delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.